In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

• Auteurs principaux: Blackmore Stuart (Auteur), Gillard Samantha (Auteur), Brown Adam P (Auteur), Trew Geoffrey H (Auteur), Clewlow Christine (Auteur), O'Donohoe Paul (Auteur), Wasiak Radoslaw (Auteur)
• Format: Livre
• Publié: BMC, 2010-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of <it>in vitro <...